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SUMMARY
A cross-sectional sero epidem iological study to detect 
the presence o f antibodies to polio virus types 1,2 and 
3 was undertaken. A total o f 437 infants with an 
average o f 40 subjects per province was enrolled in this 
study. A ll the subjects had completed the three doses o f 
TOPV.
Blood samples were aseptically collected by heel 
pricking on calibrated filter papers and immediately 
transported to the laboratory for processing. In the 
laboratory, standardized techniques were used to de­
tect neutralizing antibodies to polio virus. Antibodies 
with a titre o f >1:32 were detected in all studied 
subjects. Some infants developed litres as high as 
1:1024. However, polio virus type 3 showed a higher 
antibody titre than the other two types. Differences in 
titres were observed from province to province.
INTRODUCTION
In Zimbabwe the schedule o f immunization o f infants 
is a three dose programme o f triple oral poliom yelitis 
vaccine (TOPV), at 12,16 and 20 weeks o f age. Recent 
epidem iological data from many developing countries 
suggest that poliom yelitis is a far more serious public 
health problem than actually suspected, whereas the 
problem o f the same disease Ls far reduced or in some
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cases, eradicated in several o f the developed countries.
It has been reported that the three doses o f TOPV as 
currently recommended may not be adequate for effec­
tive protection o f infants in tropical countries due to 
poor conversion rates or due to other enteroviruses. 
Consequently paralytic poliom yelitis occurs in vacci­
nated populations, and thus may justify the recom­
mended fourth dose.
More recently studies performed in Harare at Mbare 
clin ic1 showed a good sero conversion to all three types 
of polio virus while cases o f poliom yelitis within the 
Harare area are now a rare occurrence. There are 
however, a number o f cases still being reported, but 
these cases are not confirmed by laboratory tests.
This study was designed in order to determined the 
efficacy of the TOPV in infants who had already 
received three doses.
MATERIALS AND METHODS
Study population: The study population consisted 
o f 437 infants less than nine months old who had 
completed TOPV and were brought to the clinics to 
receive the m easles vaccine. Both male and female 
candidates were included in the study. Only African 
infants were sampled since these were the only infants 
who were brought to the randomly selected clinics.
Clinics were randomly selected from all o f the 10 
provinces, however Chitungwiza was taken as the 11th 
province. Results were analyzed separately for each 
province.
C ollection o f specim ens: Samples were collected 
from volunteers only. Written consent was obtained 
from the mothers before any samples were collected. 
A ll relevant information was recorded.
Blood samples were aseptically collected by heel 
pricking on calibrated filter papers. These filter papers 
were calibrated to absorb 0,05m l o f blood. A total of 
0,10m l (2 x 0,05m l) o f blood was collected from each 
infant. Immediately after collection samples were placed 
in an ice box and were transported to the laboratory for 
processing. If not examined on the same day, samples 
were stored at -70°C, until examined.
Determ ining o f neutralizing antibodies: The neu­
tralizing antibodies were detected from the samples 
using the micro-neutralizing test which consists of two 
steps namely, virus titration and the actual neutraliza­
tion test.
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The virus titration: This was done to determine the 
right concentration o f virus to be used in the actual test. 
The virus litre was determined as the highest dilution 
giving cytopathic effect (CPE) in 50 pc o f inoculated 
cultures (TCID50).
The test procedure was performed by the micro 
technique which was done by preparing serial ten fold 
dilutions o f the p olio  viruses, types 1,2 and 3 from 
1 0 1 to 10"5. Fifty micro litres o f each virus dilution were 
added to a row o f four wells in a micro-titre plate 
already containing 50ml of maintenance media. The 
plates were than incubated for three hours at 36°C. A 
concentration o f 1 x 10 Hep2 cells/0,lm l was added to 
all the w ells containing the virus plus the cell controls. 
The plates were sealed with adhesive tape and incu­
bated at 36°C for 10 days. They were examined daily 
using an inverted microscope for appearance o f CPE. 
The titre of the virus was determined by the Karber 
Formula.
The actual m icro-neutralizing test: 25ml of main­
tenance media was added to each w ell to be used for 
assay o f serum. Serial dilutions of the eluted blood 
samples were done starting from 1:8 to 1:2 048.
This was follow ed by dilution o f 25ul standardized 
polio virus types 1,2 and 3 containing 100 TCID50 to 
every well o f poliovirus types 1,2 and 3 except the 
serum control w ells, which received 25ml o f the main­
tenance media. The plates were then incubated at 36“C 
for three hours followed by overnight incubation o f 
4 ”C. Then a concentration o f 1 x 10 Hep2 cells/0 ,lm l 
was added to all the w ells.
Appropriate controls were also included in the test. 
The plates were sealed with adhesive tapes and incu­
bated at 36°C. The plates were examined daily for 10 
days using an inverted microscope to confirm that the 
cells were monolayering, the sera were not toxic and 
that the challenge viruses were showing CPE.
RESULTS
Our o f 437 infants immunized against polio virus 
types 1,2 and 3 it was noted that all had developed 
circulating neutralizing antibodies at nine months o f 
age, with titres o f >1:32. However, distribution o f 
antibodies for each type varied from province to prov­
ince (Table 1). Although all immunized infants 
seioconverted and developed high titres (up to 1:1 024), 
waning o f antibodies was shown to increase. Our 
findings show that these infants showed a higher anti­
body titre to polio virus type 3 than the other two types 
(Figure I). On the other hand type 1 had a better 
seroconversion than type 2. It was also observed that 
several o f the infants had developed antibody titres o f 
between 1:32 and 1:1 024. Surprisingly infants from 
both Mashonaland Central and Mashonaland East had 
titres >1:512 only for type 2 which was not compatible 
with other provinces nor with other poliovirus types. 
Further, a high antibody titre for type 3 in infants from 
both Mashonaland W est and Manicaland ranged from 
1:32 to 1:64 with a decreasing scattered distribution in 
higher titres, whereas the opposite in titres was ob­
served for type 2 in Midlands and Manicaland.
Table I: Post immunization distribution o f polio virus 
neutralizing antibodies (Har=Harare, Bul=Bulawayo, 
Chi-Chitungwiza, M C=Mashonaland Central, 
ME=Mashonaland East, MW-Mashonaland West, 
MN=Matabeleland North, MS=Matabeleland South, 
Mid=Midlands, Man ^ Manicaland, Mas=Masvingo, 
Zimb=Zimbabwe).
Type Titre Province
Har Bui C h i M C  ME MW MN MS Mid Man Mas 2m b
1 32 17 17 3 9 12 20 78
64 14 11 1 9 1 9 7 5 1 4 11 73
128 5 13 14 B 3 9 7 9 2 9 5 86
256 6 7 B 2 4 5 3 7 7 17 1 67
512 5 2 22 8 13 1 3 11 12 6 1 82
1024 3 7 6 11 3 4 6 8 3 51
II 32 5 24 B 6 4 2 2 14 65
64 11 10 20 5 4 1 1 10 63
12B 11 14 11 4 5 1 2 8 57
2 5 6 12 2 3 10 9 1 4 5 2 48
5 12 7 10 4 6 13 3 11 5 3 6 0
1024 4 32 32 5 1 32 11 26 1 144
III 32 23 3 1 7 9 14 25 1 3 95
6 4 18 5 15 10 16 15 7 3 8 1 8 96
128 3 20 17 2 6 3 3 16 6 8 9 93
2 56 1 8 4 5 14 6 1 3 44
5 12 5 9 15 1 1 5 7 14 10 67
1024 5 12 3 3 14 5 42
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Figure I: Cumulative distribution o f titres fo r sero­
conversion o f antibodies for polio virus in Zimbabwe 
1989.
DISCUSSION
The introduction o f polio vaccine has drastically re­
duced both the incidence and prevalence o f poliomy­
elitis both in developed and developing countries. Very 
rare sporadic cases if  any are reported from few devel­
oping countries. In Zimbabwe occurrence o f poliom y­
elitis is now uncommon. The reduction in the preva­
lence o f the wild virus could probably be due to a high 
vaccination coverage. Even though cases o f poliomy­
elitis are becoming scarce, developing countries should 
not be relaxed, but continue with the Extended 
Programme o f Immunization against the disease.
Our study shows a 100 pc seroconversion to OPV 
after three doses. However, there were variations in 
seroconversion as per province. It should however, be 
noted thatall study infants had protection to polio virus. 
In this study, a titre o f 1:16 was considered protective. 
Sero-responses o f infants and children to three doses of 
OPV had been described elsewhere.2 Obviously in our 
study there was aprogressive increase in the titre in the 
sero-response to OPV after an additional dose. This 
was in agreement with our previous study3 and studies 
by John2, Paesa3 and Sim oes, et al* which showed a 
drastic increase in titre with subsequent doses. Al­
though all our study subjects sero-converted, there was 
somehow a very low rate o f seroresponse to poliovirus 
type 2 from the study o f infants in both Mashonaland 
Central and East.
We could not explain this. In this study we observe 
a very high rate o f sero-response to poliovirus type 3, 
which is in contrast to our previous study3 which 
showed a low rate o f seroresponse to this type.
In conclusion, we recommend continuation with 
vaccination and a close monitoring o f sero conversion, 
especially in provinces where decreased antibody titres 
were observed.
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